The impact of quasispecies dynamics on the use of therapeutics.
about
Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesisResistance of Hepatitis C Virus to Inhibitors: Complexity and Clinical ImplicationsCurrent perspectives on HIV-1 antiretroviral drug resistanceCharacteristics of HIV-1 natural drug resistance-associated mutations in former paid blood donors in Henan Province, ChinaAn Efficient Microarray-Based Genotyping Platform for the Identification of Drug-Resistance Mutations in Majority and Minority Subpopulations of HIV-1 QuasispeciesCollective Infectious Units in VirusesAttenuation of human enterovirus 71 high-replication-fidelity variants in AG129 miceEvaluation of anti-HIV-1 mutagenic nucleoside analogues.Modulation of flavivirus population diversity by RNA interference.Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif proteinArenaviruses and lethal mutagenesis. Prospects for new ribavirin-based interventions.Inference with viral quasispecies diversity indices: clonal and NGS approaches.Viral quasispecies.Extinction of West Nile virus by Favipiravir through lethal mutagenesis.Variability in mutational fitness effects prevents full lethal transitions in large quasispecies populations.Quasispecies of Hepatitis C Virus Participate in Cell-Specific Infectivity.Response of hepatitis C virus to long-term passage in the presence of alpha interferon: multiple mutations and a common phenotype.Back to the future: revisiting HIV-1 lethal mutagenesis.Lethal mutagenesis of an RNA plant virus via lethal defection.Differential Shape of Geminivirus Mutant Spectra Across Cultivated and Wild Hosts With Invariant Viral Consensus Sequences.Quasispecies and Drug Resistance
P2860
Q21132564-B94E90D8-A556-42C2-B3BB-78DE32C9268EQ26777408-424E49EA-CE5F-4A9D-81D5-802E839F009AQ26852626-2A721728-D869-4E55-92BB-75F2242D7307Q28539927-4D290424-048C-483F-B720-1D12F893D744Q28554999-2BD973F1-5962-4B81-BB7D-9B06A1D5DB90Q29464175-D9535952-8569-42A9-A3DE-913C31949D7AQ33602804-8998D357-0BF4-45FC-9ADC-AAC9FC6D8997Q34801497-815DEE69-D691-43B2-8A23-BD8BFFF9963DQ35487669-388A5933-D9DC-446F-8020-4EE745DE4438Q36432758-AB050568-3BE1-40AD-863F-B5C6D3CBD4EDQ38064285-29937C14-F96B-4AD6-B069-F95C492814A0Q38175788-180BC2A9-E9B4-425C-831D-DCFE698109CCQ38396578-B25D000C-8D21-4AD0-BB35-C3C50D13058EQ38605122-B14B4B8C-9FA7-412C-975F-E18C1850378CQ38667600-A91D2C42-33AA-43CD-955B-78E8F78E33A2Q38711204-83BB0676-EE2C-4198-ACD9-38980F2B4206Q39157496-A532A058-2011-495D-98A8-A7E0470A77FAQ39511261-6BB16955-D636-4B5C-B7AF-E471E9A274B3Q47549513-1DE01087-9423-48FB-92D0-2034DAF2F28DQ55691157-0B35C08D-3B1D-46CC-8322-FFFF412570E3Q56957250-F8052074-5A9F-4E92-9C97-A7ECA8B28025
P2860
The impact of quasispecies dynamics on the use of therapeutics.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The impact of quasispecies dynamics on the use of therapeutics.
@en
type
label
The impact of quasispecies dynamics on the use of therapeutics.
@en
prefLabel
The impact of quasispecies dynamics on the use of therapeutics.
@en
P50
P1476
The impact of quasispecies dynamics on the use of therapeutics.
@en
P2093
Celia Perales
P304
P356
10.1016/J.TIM.2012.08.010
P577
2012-09-16T00:00:00Z